Skip to main content
SpringerLink
Log in

Epidemiology of Stone Disease in North America

  • Chapter
  • First Online:
Urolithiasis

Abstract

Despite recent advances in the surgical techniques and equipment available for the management of urinary lithiasis, the prevalence of this condition continues to increase in the North American population. Associated costs are estimated to exceed 5.3 billion US dollars each year.

Epidemiological studies have implicated a range of contributory dietary, medical, environmental, and genetic factors in the pathophysiology of this disease. Many of these factors are consistent internationally. Despite this, the North American population, with its associated racial, environmental, and socioeconomic diversity, provides unique epidemiological insights. This chapter provides an overview of the risk factors for stone disease as well as incidence and prevalence patterns in a North American context using contemporary data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808–14.

    Article  PubMed  Google Scholar 

  2. Lieske JC, de la Pena Vega LS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69(4):760–4.

    Article  PubMed  CAS  Google Scholar 

  3. Hesse A, Brandle E, Wilbert D, et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44:709–13.

    Article  PubMed  CAS  Google Scholar 

  4. Johnson CM, Wilson DM, O’Fallon WM, et al. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–31.

    Article  PubMed  CAS  Google Scholar 

  5. Sierakowski R, Finlayson B, Landes RR, et al. The frequency of urolithiasis in hospital discharge diagnoses in the united states. Invest Urol. 1978;15:438–41.

    PubMed  CAS  Google Scholar 

  6. Stamatelou KK, Francis ME, Jones C, et al. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.

    Article  PubMed  Google Scholar 

  7. Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991;18:624–37.

    PubMed  CAS  Google Scholar 

  8. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–9.

    Article  PubMed  CAS  Google Scholar 

  9. Curhan GC, Rimm EB, Willett WC, et al. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol. 1994;151:838–41.

    PubMed  CAS  Google Scholar 

  10. Sarmina I, Spirnak JP. Urinary lithiasis in the black population: an epidemiological study and review of the literature. J Urol. 1987;138:14–7.

    PubMed  CAS  Google Scholar 

  11. Pearle MS, Calhoun EA, Curhan GC, et al. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848–57.

    Article  PubMed  Google Scholar 

  12. Kerbl K, Rehman J, Landman J, et al. Current management of urolithiasis; progress or regress? J Endourol. 2002;16:281–8.

    Article  PubMed  Google Scholar 

  13. Leusmann DB, Blaschke R, Schmandt W. Results of 5035 stone analysis: a contribution to epidemiology of stone disease. Scand J Urol Nephrol. 1990;24:205–10.

    Article  PubMed  CAS  Google Scholar 

  14. Daudon M, Donsimoni R, Hennequin C, et al. Sex- and age-related composition of 10617 calculi analyzed by infrared spectroscopy. Urol Res. 1995;23:319–26.

    Article  PubMed  CAS  Google Scholar 

  15. Asper R. Epidemiology and socioeconomic aspects of urolithiasis. Urol Res. 1984;12:1–5.

    Article  PubMed  CAS  Google Scholar 

  16. Gault MH, Chafe L. Relationship of frequency, age and sex, stone weight and composition in 15,624 stones: comparison of results for 1980 to 1983 and 1995 to 1998. J Urol. 2000;164:302–7.

    Article  PubMed  CAS  Google Scholar 

  17. Robertson WG, Peacock M, Heyburn PJ. Clinical and metabolic aspects of urinary stone disease in Leeds. Scand J Urol Nephrol Suppl. 1980;53(suppl):199–206.

    PubMed  CAS  Google Scholar 

  18. Curhan GC, Willett WC, Speizer FE, et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59:2290–8.

    PubMed  CAS  Google Scholar 

  19. Kourambas J, Aslan P, Teh CL, et al. Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol. 2001;15:181–6.

    Article  PubMed  CAS  Google Scholar 

  20. Curhan GC, Willett WC, Spiezer FE, et al. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128:534–40.

    PubMed  CAS  Google Scholar 

  21. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240–7.

    Article  PubMed  CAS  Google Scholar 

  22. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–93.

    Article  PubMed  Google Scholar 

  23. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–7.

    Article  PubMed  Google Scholar 

  24. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225–32.

    Article  PubMed  Google Scholar 

  25. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–5.

    Article  PubMed  Google Scholar 

  26. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62.

    Article  PubMed  CAS  Google Scholar 

  27. Cappuccino FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ. 1990;12:1234–6.

    Article  Google Scholar 

  28. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.

    Article  PubMed  CAS  Google Scholar 

  29. Ekeruo WO, Tan YH, Young MD, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004;172:159–63.

    Article  PubMed  Google Scholar 

  30. Daudon M, Lacour B, Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res. 2006;34:193–9.

    Article  PubMed  Google Scholar 

  31. Abate N, Chandalia M, Cabo-Chan Jr AV, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386–92.

    Article  PubMed  CAS  Google Scholar 

  32. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909–17.

    Article  PubMed  CAS  Google Scholar 

  33. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481–5.

    Article  PubMed  Google Scholar 

  34. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565–9.

    Article  PubMed  Google Scholar 

  35. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis as a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72:100–7.

    Article  PubMed  CAS  Google Scholar 

  36. Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol. 2009;181:2573–7.

    Article  PubMed  Google Scholar 

  37. Curhan GC, Willett W, Rimm E, et al. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–73.

    PubMed  CAS  Google Scholar 

  38. IPCC4. Climate change 2007: the physical science basis, summary for policy-makers. Fourth climate assessment report (UN Intergovernmental Panel on Climate Change, Geneva), 2007, p. 1–18.

    Google Scholar 

  39. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA. 2008;105:9841–6.

    Article  PubMed  CAS  Google Scholar 

  40. Breslau N, Brinkley L, Hill K, et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1998;66:140–6.

    Article  Google Scholar 

  41. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982;22:292–6.

    Article  PubMed  CAS  Google Scholar 

  42. Block G. Foods contributing to energy intake in the US: data from NHANES III and NHANES 1999–2000. J Food Compost Anal. 2004;17:439–47.

    Article  Google Scholar 

  43. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290:F625–31.

    Article  PubMed  CAS  Google Scholar 

  44. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104:942–50.

    Article  PubMed  Google Scholar 

  45. Ervin RB, Wright JD, Kennedy-Stephenson J. Use of dietary supplements in the United States, 1988–94. Vital Health Stat 11. 1999;244:1–14.

    Google Scholar 

  46. Slesinski MJ, Subar AF, Kahle LL. Trends in use of vitamin and mineral supplements in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc. 1995;95:921–3.

    Article  PubMed  CAS  Google Scholar 

  47. Guo X, Willows N, Kuhle S, et al. Use of vitamin and mineral supplements among Canadian adults. Can J Public Health. 2009;1004:357–60.

    Google Scholar 

  48. Traxer O, Huet B, Poindexter J, et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003;170:397–400.

    Article  PubMed  CAS  Google Scholar 

  49. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic ­kidney stones. N Engl J Med. 1993;328:833–8.

    Article  PubMed  CAS  Google Scholar 

  50. Curhan GC, Willett W, Speizer F, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497–504.

    PubMed  CAS  Google Scholar 

  51. Curhan GC, Willett W, Knight EL, et al. Dietary factors and the risk of incident kidney stones in younger women (Nurses’ Health Study II). Arch Intern Med. 2004;164:885–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Western Ontario, 268 Grosvenor Street, London, ON, N6A 4V2, Canada

    John D. Denstedt M.D., FRCSC, FACS

  2. Division of Urology, The University of Western Ontario, London, ON, Canada

    Andrew Fuller M.B.B.S., FRACS

Authors
  1. John D. Denstedt M.D., FRCSC, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Fuller M.B.B.S., FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D. Denstedt M.D., FRCSC, FACS .

Editor information

Editors and Affiliations

  1. Department of Surgery Section of Urology, Aga Khan University, Stadium Road, P.O. Box 3500, Karachi, 74800, Pakistan

    Jamsheer J. Talati

  2. Karolinska Institutet, Solnavägen 1, Solna, Stockholm, 171 77, Sweden

    Hans-Goran Tiselius

  3. , Syracuse University, Crouse Hospital, 1226 East Water Street, New York, 13210, New York, USA

    David M. Albala

  4. , Department of Urology, Tongji Hospital, 1095 Jiefang Avenue, Wuhan, 430030, China, People's Republic

    ZHANGQUN YE

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Denstedt, J.D., Fuller, A. (2012). Epidemiology of Stone Disease in North America. In: Talati, J., Tiselius, HG., Albala, D., YE, Z. (eds) Urolithiasis. Springer, London. https://doi.org/10.1007/978-1-4471-4387-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4387-1_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4383-3

  • Online ISBN: 978-1-4471-4387-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation